TGen, Jumpcode Genomics Marrying NGS, CRISPR to Build a Better COVID-19 Test

In a new article from GenomeWeb, Senior Editor Christie Rizk speaks with Nicholas Schork, Ph.D., Deputy Director and Distinguished Professor of Quantitative Medicine at The Translational Genomics Research Institute, about how Jumpcode’s CRISPRclean^® technology is helping researchers build a better COVID-19 test:

While COVID-19 held the world in its grip throughout much of 2020, the urgent need for reliable, accurate, and fast diagnostics had much of the medical community largely turning to PCR technology. But as the urgent rush for tests has abated, diagnostics developers are exploring how they can use more complex technologies like next-generation sequencing or CRISPR to create ever more accurate or informative assays.